| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
-0.55 |
0.04 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.11 |
0.04 |
| mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.04 |
| mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.05 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
| mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.05 |
| mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.05 |